Should You Establish a Position in Inspire Medical Systems (INSP)?
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Inspire Medical Systems Inc. (INSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eversept Partners Kamran Moghtaderi | 533,011 | $71,332,862 | +27% | 4.88% |
| 2. | Braidwell LP Alex Karnal | 379,443 | $50,780,857 | +274% | 1.59% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 315,098 | $42,169,565 | +310% | 0.07% |
| 4. | Iron Triangle Partners Kevin Molloy | 281,992 | $37,738,989 | 3.83% | |
| 5. | AQR Capital Management Cliff Asness | 231,845 | $31,027,817 | +153% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $153.50 | 100 | Officer | 998 | 2023-10-12 | Filing | |
| $16.00 | 62,500 | Director | 631,451 | 2018-05-07 | Filing | |
| $16.00 | 312,500 | Large Shareholder, Director | 2,444,221 | 2018-05-07 | Filing | |
| $16.00 | 312,500 | Large Shareholder | 2,444,221 | 2018-05-07 | Filing | |
| $16.00 | 3,000 | Director | 3,000 | 2018-05-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $220.00 | 800 | Director | 23,140 | 2024-09-09 | Filing | |
| $215.00 | 31 | Officer | 11,348 | 2024-09-09 | Filing | |
| $190.04 | 3,799 | Officer | 11,379 | 2024-08-22 | Filing | |
| $189.16 | 1,201 | Officer | 15,178 | 2024-08-22 | Filing | |
| $189.64 | 895 | Officer | 3,056 | 2024-08-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,257,544 | $662,682,190 | 0.05% | |
| 2. | 2,931,469 | $596,348,738 | 0.01% | |
| 3. | 1,800,207 | $366,216,270 | 0% | |
| 4. | 1,430,266 | $290,959,013 | 0.05% | |
| 5. | 1,229,879 | $250,194,284 | 0.2% |
News See All
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Second Quarter 2024 Conference Call.
Should You Consider Adding Inspire Medical Systems (INSP) Now to Your Portfolio?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Is This The Right Entry Point To Add Inspire Medical Systems (INSP)?
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Inspire Medical (INSP) Gave Back its Gains in Q2
Headwaters Capital Management, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Does Inspire Medical Systems (INSP) Hava Ample Growth Opportunity, Considering Low Market Share?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter.
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.33783, expectations were $-0.63.
Insiders Are Dumping These 5 Healthcare Stocks
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) is a clinical stage biopharma company that is working on treatments for endocrine-related diseases.
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Dilem, and I'll be your conference operator today.
Inspire Medical Systems (INSP) Experienced Volatility in 2023
Mairs & Power, an investment advisor, released the “Mairs & Power Small Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.